Spider Rock Advisors, LLC Abb Vie Inc. Put Options Transaction History

Spider Rock Advisors, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $1.92 Million - $2.21 Million	13,300 Added 511.54%	15,900 $2 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $13,831 - $16,587	-100 Reduced 3.7%	2,600 $340,000
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $302,764 - $384,912	2,200 Added 440.0%	2,700 $413,000
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $177,078 - $239,074	-2,200 Reduced 81.48%	500 $32,000
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $859,100 - $1.01 Million	-10,000 Reduced 78.74%	2,700 $156,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $579,623 - $775,622	-7,900 Reduced 38.35%	12,700 $18,000
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $270,900 - $410,718	-4,200 Reduced 16.94%	20,600 $60,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $1.63 Million - $2.08 Million	24,800 New	24,800 $87,000

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.